BCHE and Alzheimer disease: Although differences in particular medications occurred between individuals, by studying the impact of the APOE genotype within an AD population, we avoided the major confound of having most participants in one group using cholinesterase inhibitors and no participants in the other group using cholinesterase inhibitors.